SARA STARKS: Open Payments
NPI 1356831655 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,787 in 147 payments from 23 companies in 2025. Trend: 2023 $0 · 2024 $1,337 · 2025 $2,787
Food & beverage: $2,788
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 45 | $674 |
| Amgen Inc. | 25 | $378 |
| Verona Pharma, Inc. | 10 | $222 |
| Viatris Specialty LLC | 9 | $206 |
| Insmed, Inc. | 13 | $203 |
| AstraZeneca Pharmaceuticals LP | 5 | $195 |
| GENZYME CORPORATION | 7 | $193 |
| Regeneron Healthcare Solutions, Inc. | 4 | $84 |
| United Therapeutics Corporation | 4 | $66 |
| Grifols USA, LLC | 3 | $66 |
Products named: TEZSPIRE, NUCALA, TRELEGY ELLIPTA, DUPIXENT, Ohtuvayre, YUPELRI, Arikayce, Tyvaso.
Industry payments across KY — which companies pay providers there.
